 CAMBRIDGE, England, BOSTON--BUSINESS WIRE--Bicycle Therapeutics plc NASDAQ: BCYC, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide Bicycle technology, today announced an update regarding shareholder attendance at its 2021 Annual General Meeting the AGM to be held on June 28, 2021. As noted in Bicycles Notice of 2021 Annual General Meeting the Meeting Notice and the accompanying proxy statement the Pro 